In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
Giulio Molon, M.D.; Cosimo Perrone, M.D.; Massimiliano Maines, M.D.; Alessandro Costa, M.D.; Jennifer Comisso, M.D.; Alida Boi, M.D.; Eugenio Moro, M.D.; Giuseppe ...
Background: Multiple clinical trials have shown that a properly functioning implantable cardioverter-defibrillator (ICD) is capable of interrupting sudden death caused by ventricular tachyarrhythmias.
For older patients without an indication for pacing, the subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) provides results comparable to those seen with traditional ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced Medtronic has issued a recall of its implantable cardioverter defibrillators and cardiac ...
The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...
Elderly patients diagnosed with congestive heart failure who receive implantable cardioverter-defibrillators for primary prevention of sudden cardiac death live longer than those that do not. Further, ...
“This new device platform provides a number of new features that will help me to improve management of my patients with ICD and CRT-D devices, while delivering new safety features on top of St. Jude ...
An analysis of more 800 MRI examinations shows the scans do not induce clinically significant functional changes in non-MRI-conditional implantable cardioverter defibrillators, data from a ...
Researchers at Tufts Medical Center report reassuring accuracy predicting which patients with a common genetic heart disease are at the most risk of sudden death and thus most need an implanted device ...
Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...